Document is current

Any future updates will be listed below

287 Novel, boosted, fully human ROR1-targeting CAR T cells effectively eliminate hematologic and solid tumors, and resist tumor microenvironment

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0287

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark